Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Accumulation of neuronal α-synuclein is a prominent feature in Parkinson’s disease. More recently, such abnormal protein aggregation has been reported to spread from cell to cell and exosomes are considered as important mediators. The focus of such research, however, has been primarily in neurons. Given the increasing recognition of the importance of non-cell autonomous-mediated neurotoxicity, it is critical to investigate the contribution of glia to α-synuclein aggregation and spread. Microglia are the primary phagocytes in the brain and have been well-documented as inducers of neuroinflammation. How and to what extent microglia and their exosomes impact α-synuclein pathology has not been well delineated. We report here that when treated with human α-synuclein preformed fibrils, exosomes containing α-synuclein released by microglia are fully capable of inducing protein aggregation in the recipient neurons. Additionally, when combined with microglial proinflammatory cytokines, these exosomes further increased protein aggregation in neurons. Inhibition of exosome synthesis in microglia reduced α-synuclein transmission. The in vivo significance of these exosomes was demonstrated by stereotaxic injection of exosomes isolated from α-synuclein preformed fibrils treated microglia into the mouse striatum. Phosphorylated α-synuclein was observed in multiple brain regions consistent with their neuronal connectivity. These animals also exhibited neurodegeneration in the nigrostriatal pathway in a time-dependent manner. Depleting microglia in vivo dramatically suppressed the transmission of α-synuclein after stereotaxic injection of preformed fibrils. Mechanistically, we report here that α-synuclein preformed fibrils impaired autophagy flux by upregulating PELI1, which in turn, resulted in degradation of LAMP2 in activated microglia. More importantly, by purifying microglia/macrophage derived exosomes in the CSF of Parkinson’s disease patients, we confirmed the presence of α-synuclein oligomer in CD11b+ exosomes, which were able to induce α-synuclein aggregation in neurons, further supporting the translational aspect of this study. Taken together, our study supports the view that microglial exosomes contribute to the progression of α-synuclein pathology and therefore, they may serve as a promising therapeutic target for Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Microglia-derived exosomes have also been shown to carry and transfer pathogenic α-syn species, potentially further contributing to this spread [158].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [158]
The cited source says what the claim attributes to it.
In the citing paper
“Ultimately, the activation of microglia by these protein aggregates creates a feed-forward vicious cycle that aggravates neurodegeneration as activated microglia contribute to the propagation of tau, Aβ, α-synuclein, and TDP-43 into unaffected brain regions.159–164”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [163]
The cited source says what the claim attributes to it.
In the citing paper
“α-synuclein can also activate glial cells by binding to TLR261,294,295 and enhance the spreading of α-synuclein.70,296”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“They achieved this by isolating exosomes derived from microglia/macrophages in the CSF of PD patients. In doing so, they successfully detected the presence of α-syn oligomer in CD11b + exosomes.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
The cited source says what the claim attributes to it.
In the citing paper
“Another research conducted by Guo et al. showed that microglial exosomes contribute to the progression of α-syn pathology [148].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200
RetractedCeramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,627
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Autophagy is a vital pathway by which a-syn is degraded (Webb et al., 2003; Cuervo et al., 2004; Lee et al., 2004).”
BackgroundElmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Research works printed but not linked: 1
- Yun X, Guoxin Z, Chao H, Kai M, Xingfang G, Fang W, et al. Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 2019; 10: 174. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Genetics and Pathogenesis of Parkinson's Syndrome
Ye, H., Robak, L. A., Yu, M., Cykowski, M., & Shulman, J. M. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-034145 · Cited by 416
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Sengupta, U., & Kayed, R. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102270 · Cited by 293
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
Chen, L., Shen, Q., Liu, Y., Zhang, Y., Sun, L., Ma, X., Song, N., & Xie, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02071-0 · Cited by 242
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Harms, A. S., Ferreira, S. A., & Romero-Ramos, M. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02268-5 · Cited by 272
Exosomes based strategies for brain drug delivery
Rehman, F. U., Liu, Y., Zheng, M., & Shi, B. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2022.121949 · Cited by 229
STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
Hinkle, J. T., Patel, J., Panicker, N., Karuppagounder, S. S., Biswas, D., Belingon, B., Chen, R., Brahmachari, S., Pletnikova, O., Troncoso, J. C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118819119 · Cited by 240
The Role of α-Synuclein Oligomers in Parkinson’s Disease
Du, X.-Y., Xie, X.-X., & Liu, R.-T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228645 · Cited by 234
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
Li, Y., Xia, Y., Yin, S., Wan, F., Hu, J., Kou, L., Sun, Y., Wu, J., Zhou, Q., Huang, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719807 · Cited by 230
Tissue‐derived extracellular vesicles in cancers and non‐cancer diseases: Present and future
Li, S., Man, Q., Gao, X., Lin, H., Wang, J., Su, F., Wang, H., Bu, L., Liu, B., & Chen, G. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12175 · Cited by 202
Self-citationBido, S., Muggeo, S., Massimino, L., Marzi, M. J., Giannelli, S. G., Melacini, E., Nannoni, M., Gambarè, D., Bellini, E., Ordazzo, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26519-x · Cited by 190
Innate immune activation in neurodegenerative diseases
Castro-Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 162
Rastogi, S., Sharma, V., Bharti, P. S., Rani, K., Modi, G. P., Nikolajeff, F., & Kumar, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010440 · Cited by 174
Label-free microfluidic cell sorting and detection for rapid blood analysis
Lu, N., Tay, H. M., Petchakup, C., He, L., Gong, L., Maw, K. K., Leong, S. Y., Lok, W. W., Ong, H. B., Guo, R., et al. (2023) · Lab on a Chip · doi:10.1039/d2lc00904h · Cited by 158
Magalhães, P., & Lashuel, H. A. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00357-0 · Cited by 184
Exosome nanovesicles: A potential carrier for therapeutic delivery
Chavda, V. P., Pandya, A., Kumar, L., Raval, N., Vora, L. K., Pulakkat, S., Patravale, V., Salwa, Duo, Y., & Tang, B. Z. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101771 · Cited by 159
The immune system in Parkinson's disease: what we know so far
Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 173
Extracellular vesicles: Emerging tools as therapeutic agent carriers
Liu, S., Wu, X., Chandra, S., Lyon, C. J., Ning, B., Jiang, L., Fan, J., & Hu, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.002 · Cited by 158
Tu, H., Yuan, B., Hou, X., Zhang, X., Pei, C., Ma, Y., Yang, Y., Fan, Y., Qin, Z., Liu, C., et al. (2021) · Aging Cell · doi:10.1111/acel.13522 · Cited by 152
The role of glial cells in multiple sclerosis disease progression
Healy, L. M., Stratton, J. A., Kuhlmann, T., & Antel, J. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00624-x · Cited by 152
Huo, L., Du, X., Li, X., Liu, S., & Xu, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.738442 · Cited by 145
Pinnell, J. R., Cui, M., & Tieu, K. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15288 · Cited by 143
Self-citationThe emerging role of exosomes in Alzheimer’s disease
Zhang, T., Ma, S., Lv, J., Wang, X., Afewerky, H. K., Li, H., & Lu, Y. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101321 · Cited by 139
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Zang, X., Chen, S., Zhu, J., Ma, J., & Zhai, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.872134 · Cited by 139
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Brás, I. C., & Outeiro, T. F. (2021) · Cells · doi:10.3390/cells10020375 · Cited by 136
Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
Fan, Y., Chen, Z., & Zhang, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03493-6 · Cited by 134
The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
Jan, A., Gonçalves, N. P., Vægter, C. B., Jensen, P. H., & Ferreira, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158338 · Cited by 144
Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
Xia, Y., Zhang, G., Kou, L., Yin, S., Han, C., Hu, J., Wan, F., Sun, Y., Wu, J., Li, Y., et al. (2021) · Brain · doi:10.1093/brain/awab122 · Cited by 123
Border-associated macrophages in the central nervous system
Sun, R., & Jiang, H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03059-x · Cited by 135
Microglial Exosomes in Neurodegenerative Disease
Guo, M. A., Hao, Y., Feng, Y., Li, H., Mao, Y., Dong, Q., & Cui, M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.630808 · Cited by 117
Self-citationUbiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective
Guerroué, F. L., & Youle, R. J. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00667-x · Cited by 114
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
Menon, S. A., Armstrong, S. E. M., Hamzeh, A. M., Visanji, N. P., Sardi, S. P., & Tandon, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.852003 · Cited by 114
Fan, C., Wang, W. J., Yu, Z., Wang, J., Xu, W., Ji, Z., He, W., Hua, D., Wang, W., Yao, L., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02556-8 · Cited by 117
Self-citationPhosphatidylserine, inflammation, and central nervous system diseases
Ma, X., Li, X., Wang, W., Zhang, M., Yang, B., & Miao, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.975176 · Cited by 109
Estes, R., Lin, B. C., Khera, A., & Davis, M. Y. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.788695 · Cited by 109
A guide to mass spectrometric analysis of extracellular vesicle proteins for biomarker discovery
Jalaludin, I., Lubman, D. M., & Kim, J. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21749 · Cited by 100
Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Xia, X., Wang, Y., & Zheng, J. C. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00330-0 · Cited by 92
Koide, T., Mandai, S., Kitaoka, R., Matsuki, H., Chiga, M., Yamamoto, K., Yoshioka, K., Yagi, Y., Suzuki, S., Fujiki, T., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.321939 · Cited by 102
Karvandi, M. S., Hesari, F. S., Aref, A. R., & Mahdavi, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1105247 · Cited by 114
Parkinson's: A Disease of Aberrant Vesicle Trafficking
Singh, P. K., & Muqit, M. M. K. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100818-125512 · Cited by 96
Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
Yi, S., Wang, L., Wang, H., Ho, M. S.-C., & Zhang, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314753 · Cited by 102
Shen, Q., Jv, X.-H., Ma, X., Li, C., Liu, L., Jia, W., Qu, L., Chen, L., & Xie, J. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01153-z · Cited by 99
Chowen, J. A., & García‐Segura, L. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111473 · Cited by 99
Wang, C., Yang, T., Liang, M., Xie, J., & Song, N. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00265-y · Cited by 91
Potential therapeutic effects of milk-derived exosomes on intestinal diseases
Cui, Z., Amevor, F. K., Zhao, X., Mou, C., Pang, J., Peng, X., Liu, A., Lan, X., & Liu, L. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02176-8 · Cited by 94
Extracellular Vesicles for the Diagnosis and Treatment of Parkinson’s Disease
Upadhya, R., & Shetty, A. K. (2021) · Aging and Disease · doi:10.14336/ad.2021.0516 · Cited by 91
Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease
Wu, K., Xu, Q., Liu, Y., Feng, Y., Han, S., Zhang, Y.-R., Chen, S.-D., Guo, Y. X., Wu, B., Ma, L., et al. (2025) · Science · doi:10.1126/science.adp3645 · Cited by 94
Self-citationExtracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy
Ruan, J., Miao, X., Schlüter, D., Li, L., & Wang, X. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.020 · Cited by 94
Bocheva, G., Bakalov, D. V., Iliev, P., & Tafradjiiska-Hadjiolova, R. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105122 · Cited by 268
Senescent Microglia: The Key to the Ageing Brain?
Greenwood, E. K., & Brown, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094402 · Cited by 84
Rajan, S., Tryphena, K. P., Khan, S. S., Vora, L. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101915 · Cited by 86
The Roles of Exosomal Proteins: Classification, Function, and Applications
Li, X., Yang, L.-X., Wang, C., Li, H., Shi, D., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043061 · Cited by 93
Self-citationThe link between neuroinflammation and the neurovascular unit in synucleinopathies
Wang, Q., Zheng, J., Pettersson, S., Reynolds, R., & Tan, E.-K. (2023) · Science Advances · doi:10.1126/sciadv.abq1141 · Cited by 81
Ji, W., Li, Y., Peng, H., Zhao, R., Shen, J., Wu, Y., Wang, J., Hao, Q., Lü, Z., Yang, J., et al. (2021) · Advanced Materials · doi:10.1002/adma.202105711 · Cited by 82
Self-citationAlpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010360 · Cited by 87
Extracellular vesicles set the stage for brain plasticity and recovery by multimodal signalling
Hermann, D. M., Peruzzotti-Jametti, L., Giebel, B., & Pluchino, S. (2024) · Brain · doi:10.1093/brain/awad332 · Cited by 77
α-Synuclein in Parkinson's disease and advances in detection
Chen, R., Gu, X., & Wang, X. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.02.006 · Cited by 85
Zhao, K., Zheng, Q., Dyrba, M., Rittman, T., Li, A., Che, T., Chen, P., Sun, Y., Kang, X., Li, Q., et al. (2022) · Advanced Science · doi:10.1002/advs.202104538 · Cited by 80
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Deyell, J., Sriparna, M., Ying, M., & Mao, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032477 · Cited by 79
Vandendriessche, C., Bruggeman, A., Van Cauwenberghe, C., & Vandenbroucke, R. E. (2020) · Cells · doi:10.3390/cells9112485 · Cited by 73
The Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases
Ghosh, M., & Pearse, D. D. (2024) · Cells · doi:10.3390/cells13221834 · Cited by 77
CNS Border-Associated Macrophages: Ontogeny and Potential Implication in Disease
Dermitzakis, I., Theotokis, P., Evangelidis, P., Delilampou, E., Evangelidis, N., Chatzisavvidou, A., Avramidou, E., & Μanthou, M. E. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45050272 · Cited by 76
Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease
Yang, X., Li, K., Huang, H., & Ren, H. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335143 · Cited by 74
Boas, S. M., Joyce, K. L., & Cowell, R. M. (2021) · Antioxidants · doi:10.3390/antiox11010008 · Cited by 73
Gut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of Microglia
Deng, W., Yi, P., Xiong, Y., Ying, J., Lin, Y., Dong, Y., Wei, G., Wang, X., & Hua, F. (2023) · Aging and Disease · doi:10.14336/ad.2023.0727 · Cited by 72
α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis
Wang, P., Lan, G., Xu, B., Yu, Z., Tian, C., Lei, X., Meissner, W. G., Feng, T., Yang, Y., & Zhang, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00372-y · Cited by 73
Neuroinflammation in Parkinson’s Disease: Triggers, Mechanisms, and Immunotherapies
Wang, T., Shi, C., Luo, H., Zheng, H., Fan, L., Tang, M., Su, Y., Yang, J., Mao, C., & Xu, Y. (2021) · The Neuroscientist · doi:10.1177/1073858421991066 · Cited by 73
The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates
Neupane, S., Cecco, E. D., & Aguzzi, A. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167930 · Cited by 70
Bravo-Miana, R. D. C., Arizaga-Echebarria, J. K., & Otaegui, D. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00418-9 · Cited by 70
Amo‐Aparicio, J., Daly, J., Højen, J. F., & Dinarello, C. A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02830-w · Cited by 68
Research progress on the role of extracellular vesicles in neurodegenerative diseases
Li, Z., Wang, X., Wang, X., Yi, X., Wong, Y. K., Wu, J., Xie, F., Hu, D., Wang, Q., Wang, J., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00375-9 · Cited by 71
Self-citationTong, T., Duan, W., Xu, Y., Hong, H., Xu, J. M., Fu, G., Wang, X., Yang, L., Deng, P., Zhang, J., et al. (2022) · Environment International · doi:10.1016/j.envint.2022.107512 · Cited by 69
Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies
Sandau, U. S., Magaña, S. M., Costa, J., Nolan, J. P., Ikezu, T., Vella, L. J., Jackson, H. K., Moreira, L. R., Palacio, P. L., Hill, A. F., et al. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12397 · Cited by 65
Towards PET imaging of the dynamic phenotypes of microglia
Beaino, W., Janssen, B., Vugts, D. J., de Vries, H. E., & Windhorst, A. D. (2021) · Clinical and Experimental Immunology · doi:10.1111/cei.13649 · Cited by 61
Herman, S., Djaldetti, R., Mollenhauer, B., & Offen, D. (2023) · Brain · doi:10.1093/brain/awac261 · Cited by 62
Bogale, T. A., Faustini, G., Longhena, F., Mitola, S. M. F., Pizzi, M., & Bellucci, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.611761 · Cited by 67
Xiromerisiou, G., Marogianni, C., Lampropoulos, I. C., Dardiotis, E., Speletas, M. G., Ntavaroukas, P., Androutsopoulou, A., Kalala, F., Grigoriadis, N., & Papoutsopoulou, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010264 · Cited by 65
Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms
Stefanova, N., & Wenning, G. K. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00697-7 · Cited by 64
Filannino, F. M., Panaro, M. A., Benameur, T., Pizzolorusso, I., & Porro, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031629 · Cited by 60
“Other stimuli that induce EV secretion from cultured microglia are: pro-inflammatory cytokines [171,172], IL-4 [173,174], capsaicin [175,176], ethanol [177], and manganese [178].”
BackgroundTools and Approaches for Studying Microglia In vivo
Eme-Scolan, E., & Dando, S. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583647 · Cited by 57
Li, G., Liu, J., Guan, Y., & Ji, X. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13754 · Cited by 59
Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease
Zheng, T., & Zhang, Z. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105094 · Cited by 61
Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading
Aires, I. D., Ribeiro‐Rodrigues, T., Boia, R., Ferreira-Rodrigues, M., Girão, H., Ambrósio, A. F., & Santiago, A. R. (2021) · Biomolecules · doi:10.3390/biom11060770 · Cited by 60
Thi Lai, T., Kim, Y. E., Nguyen, L. T. N., Thi Nguyen, T., Kwak, I. H., Richter, F., Kim, Y. J., & Ma, H.-I. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00640-2 · Cited by 72
“These results are in line with previous studies that utilized another CSF1R inhibitor, PLX3397, and demonstrate that microglial depletion reduced exogenous α Syn in the substantia nigra 19,20 .”
ResultInflammasome Activation in Parkinson’s Disease
Jewell, S. L., Herath, A. M., & Gordon, R. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223338 · Cited by 61
The multiple faces of extracellular vesicles released by microglia: Where are we 10 years after?
Gabrielli, M., Raffaele, S., Fumagalli, M., & Verderio, C. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.984690 · Cited by 60
Zhang, W., Ding, L., Chen, H., Zhang, M., Ma, R., Zheng, S., Gong, J., Zhang, Z., Xu, H., Xu, P., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05807-y · Cited by 58
Wang, L., Zhang, X., Yang, Z., Wang, B., Gong, H., Zhang, K., Lin, Y., & Sun, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00453-6 · Cited by 58
Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s Disease
Leggio, L., Paternò, G., Vivarelli, S., Falzone, G. G., Giachino, C., Marchetti, B., & Iraci, N. (2021) · Aging and disease · doi:10.14336/ad.2021.0527 · Cited by 55
Neuroprotective and Neurotoxic Effects of Glial-Derived Exosomes
Oyarce, K., Cepeda, M. Y., Lagos, R., Garrido, C., Vega-Letter, A. M., Garcia-Robles, M., Luz-Crawford, P., & Elizondo-Vega, R. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.920686 · Cited by 51
Aires, I. D., Ribeiro‐Rodrigues, T., Boia, R., Catarino, S., Girão, H., Ambrósio, A. F., & Santiago, A. R. (2020) · Glia · doi:10.1002/glia.23880 · Cited by 60
Neurons and Glia Interplay in α-Synucleinopathies
Mavroeidi, P., & Xilouri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094994 · Cited by 62
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Wang, R., Ren, H., Kaznacheyeva, E. V., Lu, X., & Wang, G. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00957-z · Cited by 56
Zhang, J., Zhang, N., Lei, J., Jing, B., Li, M., Tian, H., Xue, B., & Li, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109417 · Cited by 59
Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers
Wu, S., Hernandez Villegas, N. C., Sirkis, D. W., Thomas-Wright, I., Wade-Martins, R., & Schekman, R. (2023) · eLife · doi:10.7554/elife.85837 · Cited by 52
SPP1 derived from silica-exposed macrophage exosomes triggers fibroblast transdifferentiation
Huang, R., Hao, C., Wang, D., Zhao, Q., Li, C. R., Wang, C., & Yao, W. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115559 · Cited by 74
Natale, F., Fusco, S., & Grassi, C. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00326-w · Cited by 54
α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders
Hatano, T., Okuzumi, A., Matsumoto, G., Tsunemi, T., & Hattori, N. (2024) · Journal of Movement Disorders · doi:10.14802/jmd.24075 · Cited by 56
Metadata
- Authors
- Guo, M., Wang, J., Zhao, Y., Feng, Y., Han, S., Dong, Q., Cui, M., & Tieu, K.
- Affiliations
- Fudan University (CN)
- Tongji University (CN)
- Shanghai Medical College of Fudan University (CN)
- Florida International University (US)
- Corresponding author
- Dong, Qiang
- Cui, Mei
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-01
- Volume
- 143
- Issue
- 5
- Pages
- 1476-1497
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC7241957
- OpenAlex
- W3022628169
- Cited by
- 522
- References
- 70
- Citations by year
- 2026: 76 · 2025: 103 · 2024: 102 · 2023: 84 · 2022: 84 · 2021: 60 · 2020: 12
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81971013, 81870915, 81571109, 81571232)
- Science and Technology Commission of Shanghai Municipality (16411970200)
- National Institute of Environmental Health Sciences (R01-ES022274, R35-ES030523)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- Parkinson's disease, alpha-synuclein, protein aggregation, prion-like spread, neuroinflammation, autophagy, PELI1, LAMP2, nigrostriatal degeneration, microglia depletion, therapeutic target
- MeSH terms
- Animals, Brain, Humans, Mice, Inbred C57BL, Neurons, Parkinson Disease, Microglia, Mice, alpha-Synuclein, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.